Quantum-Si Incorporated announced on June 24, 2025, the placement of its Platinum Pro instrument at the Broad Institute. This collaboration aims to support scientific innovation across oncology, therapeutics, and other key areas of biomedical research.
This placement expands access to single-molecule protein sequencing within the Broad Institute and the Greater Boston life science ecosystem. Researchers in the region will now have opportunities to collaborate on advanced applications such as high-resolution protein identification and protein barcoding for multiplexed screening.
The collaboration underscores a shared vision for accelerating discovery through transformative proteomics technologies. This strategic placement provides significant validation and visibility for Quantum-Si's next-generation tools within a leading research institution.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.